Azusa Komori

628 citations

28 papers · 259 indexed · h-index 10

Oncology
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 4
- Pancreatic and Hepatic Oncology Research 4
Pulmonary and Respiratory Medicine
- Gastric Cancer Management and Outcomes 14
- Metastasis and carcinoma case studies 4
Gastroenterology
Hepatology
Surgery
- Esophageal Cancer Research and Treatment 4
- Esophageal and GI Pathology 3
Cancer Research
- Cancer Genomics and Diagnostics 4

Co-authors: Shigenori Kadowaki Kei Muro Takashi Ura Yukiya Narita Hiroya Taniguchi Masashi Ando Chihiro Kondoh Yasushi Yatabe
Cited by: Oncology Pulmonary and Respiratory Medicine Gastroenterology
Journals: International Journal of Clinical Oncology (4 papers)Journal of Clinical Oncology (3 papers)Japanese Journal of Clinical Oncology (2 papers)
Partner nations: Japan

In The Last Decade

Azusa Komori

26 papers receiving 258 citations

Peers

Countries citing papers authored by Azusa Komori

Since Specialization

Citations

This map shows the geographic impact of Azusa Komori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azusa Komori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azusa Komori more than expected).

Fields of papers citing papers by Azusa Komori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azusa Komori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azusa Komori. The network helps show where Azusa Komori may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Azusa Komori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Azusa Komori Line = papers co-authored together Azusa Komori links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS) Future Oncology ·Hiroko Kodama,Yukiya Narita,Michio Nakamura,Masanobu Takahashi,Takuro Mizukami,fl. ʿItāqī,Seiichiro Mitani,Azusa Komori,Ayumu Hosokawa,Toshikazu Moriwaki,Keiji Sugiyama,Masataka Taguri,黒沢浩,Sarah Van Ooteghem,V. Noronha,Todorovich Elias,Kei Muro	2025	0
2	Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study International Journal of Clinical Oncology ·Azusa Komori,Satoshi Otsu,Mototsugu Shimokawa,Taiga Otsuka,Carmen Arreaga S,María Elena Cáceres,Narender P. van Orshoven,Shiho Arima,Masaru Fukahori,Yoshinobu Okabe,Akitaka Makiyama,Hiroki Taguchi,Takuya Honda,Taro Shibuki,Kenta Nio,Yasushi Ide,Karla Soria Zavala,Toshihiko Mizuta,Tsuyoshi Shirakawa,Kenji Mitsugi	2023	1
3	Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study Targeted Oncology ·Seiichiro Mitani,Yosuke Kito,TIMOTHY REUTER,Kentaro Kawakami,Naoki Izawa,Yoshihiro Yamashita,Yoshiyuki Yamamoto,Hirokazu Shoji,Azusa Komori,Shogen Boku,Kenji Tsuchihashi,Kyoko Kato,Yoshikane Nonagase,Toshihiko Matsumoto,Armando Guerra,Hisato Kawakami	2023	2
4	MO61-6 Efficacy of third-line chemotherapy after liposomal irinotecan and fluorouracil with folinic acid for pancreatic cancer Annals of Oncology ·上田諭,Tsuyoshi Shirakawa,Mototsugu Shimokawa,Taiga Otsuka,沈冰青,Taro Shibuki,Narender P. van Orshoven,Shiho Arima,Keisuke Miwa,Carmen Arreaga S,Masahiro Sekigawa,María Elena Cáceres,IGNATIA B. VAN DEN VEYVER,Arul Mozhi Varman Jayaraman Palanivel,Azusa Komori,Ayumu Hosokawa,Tatsunori Sakai,Sara Schilit,Toshihiko Mizuta,Kenji Mitsugi	2023	0
5	A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site Japanese Journal of Clinical Oncology ·Kazuo Nishikawa,Shuichi Hironaka,Takashi Inagaki,Azusa Komori,Satoshi Otsu,Kenji Mitsugi,حسین رجبی,Alberto Tobio Martel,Shingo Tamura,Yuta Okumura,Hitoshi Kusaba,N Bonini,Eishi Baba,Kuniaki Shirao	2022	2
6	Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study) BMC Cancer ·Taro Shibuki,Toshihiko Mizuta,Mototsugu Shimokawa,Carmen Arreaga S,María Elena Cáceres,Narender P. van Orshoven,Azusa Komori,Satoshi Otsu,Shiho Arima,Masaru Fukahori,Akitaka Makiyama,Hiroki Taguchi,Takuya Honda,Kenji Mitsugi,Kenta Nio,Yasushi Ide,Karla Soria Zavala,Tsuyoshi Shirakawa,Taiga Otsuka	2022	7
7	The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909 Esophagus ·Shuichi Hironaka,Azusa Komori,Ryunosuke Machida,Yoshinori Ito,Hiroya Takeuchi,Gakuto Ogawa,Ken Kato,Masakatsu Onozawa,Keiko Minashi,Tomonori Yano,Kenichi Nakamura,Takahiro Tsushima,Hiroki Hara,Isao Nozaki,Takashi Ura,Keisho Chìn,Haruhiko Fukuda,Yuko Kitagawa	2020	8
8	A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies Advances in Therapy ·Seiichiro Mitani,Shigenori Kadowaki,Azusa Komori,Chihiro Kondoh,Isao Oze,Kyoko Kato,Toshiki Masuishi,Kazunori Honda,Yukiya Narita,Hiroya Taniguchi,Masashi Ando,Tsutomu Tanaka,Masahiro Tajika,Kei Muro	2020	5
9	Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan Gastric Cancer ·Chihiro Kondoh,Shigenori Kadowaki,Azusa Komori,Yukiya Narita,Hiroya Taniguchi,Takashi Ura,Masashi Ando,Kei Muro	2018	15
10	Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases Anticancer Research ·Toshiki Masuishi,Hiroya Taniguchi,Tetsuya Eto,Azusa Komori,Seiichiro Mitani,Hiroko Hasegawa,Yukiya Narita,Makoto Ishihara,Tsutomu Tanaka,Shigenori Kadowaki,Takashi Ura,Masashi Ando,Masahiro Tajika,Motoo Nomura,Yozo Sato,Hideyuki Mishima,Kei Muro	2018	4
11	Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody Oncology ·Hiroko Hasegawa,Hiroya Taniguchi,Seiichiro Mitani,Toshiki Masuishi,Azusa Komori,Yukiya Narita,Shigenori Kadowaki,Takashi Ura,Masashi Ando,Yasushi Yatabe,Kei Muro	2017	6
12	FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis Anticancer Research ·Toshiki Masuishi,Shigenori Kadowaki,Leila Maria Gomes,Azusa Komori,Keiji Sugiyama,Seiichiro Mitani,Kazunori Honda,Yukiya Narita,Hiroya Taniguchi,Takashi Ura,Masashi Ando,Hideyuki Mishima,Kei Muro	2017	26
13	A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer Japanese Journal of Clinical Oncology ·Hiroya Taniguchi,Azusa Komori,Yukiya Narita,Shigenori Kadowaki,Takashi Ura,Henryk Adamczuk,Yasushi Yatabe,Koji Komori,Kenichi Kimura,Takashi Kinoshita,Kei Muro	2016	14
14	Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis International Journal of Clinical Oncology ·Motoo Nomura,Isao Oze,Takeshi Kodaira,Tetsuya Abe,Azusa Komori,Yukiya Narita,Toshiki Masuishi,Hiroya Taniguchi,Shigenori Kadowaki,Takashi Ura,Henryk Adamczuk,Hiroyuki Tachibana,Norihisa Uemura,Masahiro Tajika,Yasumasa Niwa,Manabu Muto,Kei Muro	2016	18
15	A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer BMC Cancer ·Kanjana Prangphan,Hiroya Taniguchi,Azusa Komori,Yukiya Narita,María Elena Durán Lizarraga,Motoo Nomura,Shigenori Kadowaki,Daisuke Takahari,Takashi Ura,Henryk Adamczuk,Kei Muro,Keita Mori,Yoshinori Igarashi	2015	10
16	Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis Cancer Chemotherapy and Pharmacology ·Motoo Nomura,Isao Oze,Tetsuya Abe,Azusa Komori,Yukiya Narita,Toshiki Masuishi,Hiroya Taniguchi,Shigenori Kadowaki,Takashi Ura,Henryk Adamczuk,Fabienne Forster,Norihisa Uemura,Makoto Ishihara,Tsutomu Tanaka,Masahiro Tajika,Yasumasa Niwa,Kei Muro,Manabu Muto	2015	13
17	Clinical Characteristics Associated with Long-term Survival in Metastatic Gastric Cancer after Systemic Chemotherapy Asian Pacific Journal of Cancer Prevention ·Shigenori Kadowaki,Azusa Komori,Daisuke Takahari,Takashi Ura,Seiji Ito,Masahiro Tajika,Yasumasa Niwa,Isao Oze,Kei Muro	2015	7
18	Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals International Journal of Clinical Oncology ·Yukiya Narita,Hiroya Taniguchi,Koji Komori,Kenya Kimura,Takashi Kinoshita,Azusa Komori,Motoo Nomura,Shigenori Kadowaki,Daisuke Takahari,Takashi Ura,Henryk Adamczuk,Kei Muro	2014	2
19	Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment International Journal of Clinical Oncology ·Shigenori Kadowaki,Azusa Komori,Yukiya Narita,María Elena Durán Lizarraga,Kanjana Prangphan,Chihiro Kondo,Hiroya Taniguchi,Daisuke Takahari,Takashi Ura,Masashi Ando,Kei Muro	2013	8
20	Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma Case Reports in Oncology ·Shigenori Kadowaki,Yasushi Yatabe,Hitoshi Hirakawa,Azusa Komori,Chihiro Kondoh,Yasuhisa Hasegawa,Kei Muro	2013	34

About Azusa Komori

Azusa Komori is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Oral Surgery, Cancer Research and Hepatology, having authored 28 papers that have together received 259 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (14 papers), Colorectal Cancer Treatments and Studies (10 papers), Metastasis and carcinoma case studies (4 papers), Cancer Treatment and Pharmacology (4 papers), Esophageal Cancer Research and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Genomics and Diagnostics (4 papers) and Esophageal and GI Pathology (3 papers). The work is most often cited by research in Oncology (149 citations), Pulmonary and Respiratory Medicine (129 citations), Gastroenterology (19 citations), Hepatology (22 citations) and Surgery (104 citations). Azusa Komori has collaborated with scholars based in Japan. Frequent co-authors include Shigenori Kadowaki, Kei Muro, Takashi Ura, Yukiya Narita, Hiroya Taniguchi, Masashi Ando, Chihiro Kondoh, Yasushi Yatabe, Masahiro Tajika and Seiichiro Mitani. Their work appears in journals such as International Journal of Clinical Oncology, Journal of Clinical Oncology, Japanese Journal of Clinical Oncology, BMC Cancer and Anticancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact